Molecular docking and molecular dynamics simulation study of inositol phosphorylceramide synthase – inhibitor complex in leishmaniasis: Insight into the structure based drug design

Abstract

Inositol phosphorylceramide synthase (IPCS) has emerged as an important, interesting and attractive target in the sphingolipid metabolism of Leishmania. IPCS catalyzes the conversion of ceramide to IPC which forms the most predominant sphingolipid in Leishmania. IPCS has no mammalian equivalent and also plays an important role in maintaining the infectivity and viability of the parasite. The present study explores the possibility of targeting IPCS; development of suitable inhibitors for the same would serve as a treatment strategy for the infectious disease leishmaniasis. Five coumarin derivatives were developed as inhibitors of IPCS protein. Molecular dynamics simulations of the complexes of IPCS with these inhibitors were performed which provided insights into the binding modes of the inhibitors. In vitro screening of the top three compounds has resulted in the identification of one of the compounds (compound 3) which shows little cytotoxic effects. This compound therefore represents a good starting point for further in vivo experimentation and could possibly serve as an important drug candidate for the treatment of leishmaniasis.

Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach

“…and molecular dynamics (MD) simulation are a widely used method for the exploration of novel inhibitors against a target protein (Jani and Dalafave, 2012). MD simulation provides information regarding the time dependent behavior of any molecular system by integrating Newton's laws of motion (Mandlik and Singh, 2016). The stability of the docked complexes were determined by performing an MD simulation as previously described (Al-Shabib et al, 2018;AlAjmi et al, 2018).…”

A novel strategy for engineering of a smart generation of immune ribonucleases against EGFR+ cells

“…Therefore, to avoid any bias, MDS methods were applied in this study. MDS studies can perform the docking simulation by releasing protein docking results or protein−ligand in the simulation environment to confirm the protein docking results (Gioia et al, 2017; Mandlik & Singh, 2016). One of the major problems in using MDS for antibodies and immunotoxin engineering is that it demands complicated calculations and powerful computers due to the large size of immunotoxins and ligand complexes.…”

“…Therefore, to avoid any bias, MDS methods were applied in this study. MDS studies can perform the docking simulation by releasing protein docking results or protein−ligand in the simulation environment to confirm the protein docking results (Gioia et al, 2017;Mandlik & Singh, 2016).…”

Exploiting receptor flexibility to improve the accuracy of structure-based virtual screening

“…In addition, MD simulation is also used as a post-docking application to refine the protein-ligand interactions predicted by docking algorithms [195][196][197][198][199]. In classical molecular docking, the ligand can undergo large conformational changes.…”